Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.37 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27586525 | 0.90 | TSHR (0.46) | TSHRTDP1CYP3A4MAPTCACNA1B | |
| SCHEMBL12913875 | 0.88 | TSHR (0.44) | TSHRTDP1CYP3A4MAPTCACNA1B | |
| SCHEMBL2908750 | 0.86 | TSHR (0.47) | TSHRTDP1CYP3A4MAPTCACNA1B | |
| Hydrochloric Acid SCHEMBL28013648 | 0.86 | TSHR (0.43) | TSHRTDP1CYP3A4MAPTCACNA1B | |
| SCHEMBL1024024 | 0.85 | CA2 (0.59) | TSHRTDP1CYP3A4CA1CA2 | |
| SCHEMBL10495787 | 0.83 | CA2 (0.44) | TSHRTDP1CYP3A4MAPTCACNA1B | |
| SCHEMBL15443382 | 0.83 | CA2 (0.53) | TSHRTDP1CA1CA2HPGD | |
| SCHEMBL15442976 | 0.83 | TSHR (0.47) | TSHRTDP1CYP3A4MAPTCACNA1B | |
| SCHEMBL14331822 | 0.82 | TSHR (0.46) | TSHRTDP1CYP3A4MAPTCACNA1B | |
| SCHEMBL15442774 | 0.82 | TSHR (0.56) | TSHRTDP1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119823682-A | OCA adhesive material, preparation method thereof and application thereof in preparation of OCA adhesive film | 宁波激智科技股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-103319521-A | Cyclic siloxane compositions for the release of active ingredients | GEN ELECTRIC | 2013-09-25 | — | — | CN | claimed |
| JP-4739231-B2 | — | — | 2011-08-03 | — | — | JP | claimed |
| EP-1716159-B1 | BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-13 | — | — | EP | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| US-7579495-B2 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2009-08-25 | — | — | US | claimed |
| US-7576170-B2 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS (US) | 2009-08-18 | — | — | US | claimed |
| CN-100522127-C | Perfume composition | KAO CORP (JP) | 2009-08-05 | — | — | CN | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| EP-1716159-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | General Electronic Company (US) | 2006-11-02 | — | — | EP | claimed |
| EP-1697386-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | General Electric Company A Corporation of the State of New York (US) | 2006-09-06 | — | — | EP | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| CN-122016980-A | In-situ real-time determination method, system and application of fragrance dynamic change in black tea drying process | 中国农业科学院茶叶研究所 | 2026-05-12 | — | — | CN | disclosed |
| US-20250344991-A1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-11-13 | — | — | US | disclosed |
| US-20040197278-A1 | Chewable compositions with odour absorbing agents | THE PROCTER & GAMBLE COMPANY | 2004-10-07 | — | — | US | disclosed |
| WO-2003017775-A1 | CHEWABLE COMPOSITIONS WITH ODOUR ABSORBING AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 2003-03-06 | — | — | WO | disclosed |
| EP-1287746-A1 | Chewable compositions with odour absorbing agents | THE PROCTER & GAMBLE COMPANY (US) | 2003-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | TSHR 4528/4885TDP1 3632/4885CYP3A4 1847/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | TSHR 4168/4885TDP1 3581/4885CYP3A4 2149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.